Mohamed A. Eldeeb
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Epidemiology top 10%
- Autophagy in Disease and Therapy
Papers in
-
- Ubiquitin and proteasome pathways 19
- Protein Degradation and Inhibitors 10
- Mitochondrial Function and Pathology 8
- Epidemiology 14
- Autophagy in Disease and Therapy 14
- Co-authors
- Mohamed A. Ragheb (14 shared papers)Richard P. Fahlman (13 shared papers)Edward A. Fon (11 shared papers)Rhalena A. Thomas (2 shared papers)Mansoore Esmaili (11 shared papers)Jean‐François Trempe (6 shared papers)Cornelia E. Zorca (7 shared papers)Thomas Goiran (3 shared papers)
- Journals
- BioEssays (4 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)Neurotoxicity Research (2 papers)Cells (2 papers)Molecular Cell (2 papers)
- Partner nations
- CanadaEgyptUnited States
In The Last Decade
Mohamed A. Eldeeb
43 papers receiving 819 citations
Mohamed A. Eldeeb's Hit Papers
Peers
Comparison fields: 5 of 82
- Neurology 172
- Epidemiology 234
- Molecular Biology 492
- Clinical Biochemistry 40
- Cell Biology 98
Countries citing papers authored by Mohamed A. Eldeeb
This map shows the geographic impact of Mohamed A. Eldeeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed A. Eldeeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed A. Eldeeb more than expected).
Fields of papers citing papers by Mohamed A. Eldeeb
This network shows the impact of papers produced by Mohamed A. Eldeeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed A. Eldeeb. The network helps show where Mohamed A. Eldeeb may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohamed A. Eldeeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial quality control in health and in Parkinson’s disease Hit paper breakdown → | 2022 | 178 |
| 2 | 2021 | 77 | |
| 3 | 2024 | 48 | |
| 4 | 2019 | 44 | |
| 5 | 2016 | 36 | |
| 6 | 2014 | 31 | |
| 7 | 2018 | 30 | |
| 8 | 2020 | 28 | |
| 9 | 2023 | 27 | |
| 10 | 2020 | 25 | |
| 11 | 2016 | 25 | |
| 12 | 2019 | 23 | |
| 13 | 2022 | 22 | |
| 14 | 2022 | 19 | |
| 15 | 2019 | 18 | |
| 16 | 2017 | 17 | |
| 17 | 1986 | 14 | |
| 18 | 2018 | 13 | |
| 19 | 2025 | 12 | |
| 20 | 2017 | 12 |
About Mohamed A. Eldeeb
Mohamed A. Eldeeb is a scholar working on Molecular Biology, Epidemiology, Oncology, Cell Biology and Neurology, having authored 48 papers that have together received 823 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (19 papers), Autophagy in Disease and Therapy (14 papers), Protein Degradation and Inhibitors (10 papers), Peptidase Inhibition and Analysis (9 papers), Mitochondrial Function and Pathology (8 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Cellular transport and secretion (4 papers). The work is most often cited by research in Neurology (172 citations), Epidemiology (234 citations), Molecular Biology (492 citations), Clinical Biochemistry (40 citations) and Cell Biology (98 citations). Mohamed A. Eldeeb has collaborated with scholars based in Canada, Egypt and United States. Frequent co-authors include Mohamed A. Ragheb, Richard P. Fahlman, Edward A. Fon, Rhalena A. Thomas, Mansoore Esmaili, Jean‐François Trempe, Cornelia E. Zorca, Thomas Goiran, Naoto Soya and Simon Veyron. Their work appears in journals such as BioEssays, Anti-Cancer Agents in Medicinal Chemistry, Neurotoxicity Research, Cells and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.